Endocrine Emergencies Flashcards
Hypoglycemia defined
Glucose < 70 mg/dL
Symptomatic hypoglycemia with levels <50
Risk factors for hypoglycemia in type II diabetes
Age
PMHx of vascular disease
Renal failure
Decreased food intake
Alcohol use
Drug interactions
Non compliance
Hypoglycemia sympathomimetic symptoms
Sweating, tremor, pallor, nausea,
anxiety, palpitations
Hypoglycemia Neuroglycopenia symptoms
Dizziness, psychosis, confusion, coma,
agitation, seizures
Hypoglycemia additional causes
● Insulinoma- Pancreatic islet cell tumor (90% benign)
● Medications/Drugs/Alcohol
● Extrapancreatic neoplasm
● Hepatic disease(depletion of glycogen stores)
● Deficiency of counterregulatory hormones
● Critically ill, stressed infants, hypothermia
● Dumping syndrome
● Artifactual
Hypoglycemia treatment
Standard treatment options
- Oral Glucose
Sugar Water
- D50 (50% dextrose in water) - 50 mL bolus provides 25gm of glucose (500mg/mL)
- D25 (peds)
- D10 (neonates)
- Maintain glucose at > 100 mg/dL
Recheck blood sugar q30 mins
- IV infusion of D10 (10% dextrose in water) or oral to maintain blood sugar
Glucagon 1mg IM/IV
- Stimulates glycogenolysis
- Can raise BS by ↑ 100mg/dL
- Works slower (10-15 minutes)
secondary causes of hypoglycemia if failure to respond to initial therapy
Sepsis, toxin, insulinoma, hepatic failure, adrenal insufficiency
Octreotide (Sandostatin)
- Inhibits insulin secretion
- Helps prevent rebound hypoglycemia in setting of glucose Infusion treatment and persistent symptoms refractory to
sulfonylurea-induced hypoglycemia (As an antidote) - 50-100 mcg SC or IV
Give _____ with glucose in malnourished hypoglycemic patients
thiamine
Diagnosis of DM
- Fasting glucose (100-125 mg/dL)
- Random glucose (>200 mg/dL)
- 2 hour oral glucose tolerance (>200 mg/dL)
- HbA1c of >6.5%
Severe Hyperglycemia (>300 mg/dL) treatment
- Fluids IV
- Insulin -Regular insulin at 0.1- 0.15 units/kg IV or SC (IV better absorption)
Appropriate to initiate Metformin 500 mg qDay - Make sure creatinine is normal
- If modest elevation, inform patient of concern, F/U PCP
Hypoglycemic medications
- Sulfonylurea agents:
- (2nd gen) Glipizide, glimepiride, glyburide
- Stimulate pancreatic insulin secretion
- Cause profound hypoglycemia in OD
- Long duration of action
- Repaglinide (Prandin)
- Stimulates insulin secretion
- Can also cause hypoglycemia
Antihyperglycemic Agents (less likely to cause hypoglycemia in overdose)
Metformin
- Rarely causes lactic acidosis
Less risk of hypoglycemia
GLP-1 agonist
SGLT2 inhibitors
DPP-4 inhibitors
Thiazolidinediones
Diabetic Ketoacidosis Pathophysiology
Defined as cellular starvation due to relative or a
complete lack of insulin:
- Hyperglycemia
- Osmotic diuresis
- Prerenal Azotemia
- Ketone formation
- Wide anion gap metabolic acidosis
Free Fatty acids are converted to Ketones
in the liver → ______
Metabolic Acidosis
Hyperglycemia effects on the body
Glycosuria
Osmotic diuresis
Decreased GFR
Intracellular dehydration
Impaired consciousness
Shock
(Table on slide 20)
Loss of islet cell function in DKA causes what effects on the body?
- Autoimmune destruction → Type I
- Leads to inability of cells to use glucose for fuel, despite
increased levels of intravascular glucose - Breaks down protein and adipose stores
- Increased counterregulatory hormones further leads to
ketonemia and increased hyperglycemia (Osmotic Diuresis)
Precipitants of DKA
Noncompliance with Insulin
Infection
Myocardial Infarction
Pregnancy (IUP)
CVA
Trauma
Hyperthyroidism
Pancreatitis
Any acute stressor
Metabolic acidosis causes compensatory ____
hyperventilation
- Kussmaul breathing
- Acetone leads to fruity breath smell
Avenues of volume loss in DKA
- Osmotic Diuresis
- Vomiting (Acidosis)
- Loss of potassium
- Leads to further hyperglycemia
- Poor absorption of SC Insulin
- Leads to poor Hemodynamics
Diabetic Ketoacidosis diagnosis
- Glucose >250 mg/dL
- Anion gap > 10 mEq/L
- Bicarbonate < 15 mEq/L
- pH < 7.3